Release Date: 13/07/12 09:01 Summary: Woodlawn Mineralisation Confirmed Price Sensitive: Yes Download Document 114.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%